These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19284498)

  • 1. Activated T cells inhibit NK cell-mediated tumour rejection.
    Wang XJ; Hu J; Yuan J; Peng YM; Gui L; He WF; Tan J; Luo GX; Wu J
    Scand J Immunol; 2009 Apr; 69(4):337-41. PubMed ID: 19284498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerant T cells inhibit natural killer cells function in antigen-presenting cells in an independent fashion.
    Wang X; Yuan J; Hu J; Wu J; Gan C; He W; Luo G
    Transplant Proc; 2009 Jun; 41(5):1844-7. PubMed ID: 19545741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F; Basse PH; Hokland M
    Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of tumoricidal NK and NK T cell activities by MHC Kb molecules expressed on Th2-type gammadelta T and alphabeta T cells coinfiltrating in early B16 melanoma lesions.
    Seo N; Tokura Y; Furukawa F; Takigawa M
    J Immunol; 1998 Oct; 161(8):4138-45. PubMed ID: 9780186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of natural killer cell differentiation by activated T lymphocytes in long-term cultures of mouse bone marrow.
    Delfino DV; Lepri E; Ayroldi E; Migliorati G; Boggs SS; Riccardi C
    Exp Hematol; 1998 Jan; 26(1):2-9. PubMed ID: 9430508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal regulation between natural killer cells and autoreactive T cells.
    Shi FD; Van Kaer L
    Nat Rev Immunol; 2006 Oct; 6(10):751-60. PubMed ID: 16998508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltration and lysis of tumour cell aggregates by adherent interleukin-2-activated natural killer cells is distinct from specific cytolysis.
    Johansson BR; Unger ML; Albertsson P; Casselbrant A; Nannmark U; Hokland M
    Nat Immun; 1996-1997; 15(2-3):87-97. PubMed ID: 9162267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK cell regulation of T cell-mediated responses.
    Zingoni A; Sornasse T; Cocks BG; Tanaka Y; Santoni A; Lanier LL
    Mol Immunol; 2005 Feb; 42(4):451-4. PubMed ID: 15607797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR8-driven IL-12-dependent reciprocal and synergistic activation of NK cells and monocytes by immunostimulatory RNA.
    Berger M; Ablasser A; Kim S; Bekeredjian-Ding I; Giese T; Endres S; Hornung V; Hartmann G
    J Immunother; 2009 Apr; 32(3):262-71. PubMed ID: 19242374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-12 secreted by mature dendritic cells mediates activation of NK cell function.
    Alli RS; Khar A
    FEBS Lett; 2004 Feb; 559(1-3):71-6. PubMed ID: 14960310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells.
    Gros F; Cabillic F; Toutirais O; Maux AL; Sebti Y; Amiot L
    Eur J Immunol; 2008 Mar; 38(3):742-9. PubMed ID: 18266268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
    Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
    J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo - role of KARAP/DAP12-dependent and -independent pathways.
    Oberg L; Johansson S; Michaëlsson J; Tomasello E; Vivier E; Kärre K; Höglund P
    Eur J Immunol; 2004 Jun; 34(6):1646-53. PubMed ID: 15162434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hsBAFF enhances activity of NK cells by regulation of CD4(+) T lymphocyte function.
    Zhang W; Wen L; Huang X; Liang J; Gao W; Zhang S; Chen L
    Immunol Lett; 2008 Oct; 120(1-2):96-102. PubMed ID: 18687360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative activation up-regulates expression of CD4 and HIV-1 co-receptors on NK cells and induces their infection with HIV-1.
    Harada H; Goto Y; Ohno T; Suzu S; Okada S
    Eur J Immunol; 2007 Aug; 37(8):2148-55. PubMed ID: 17628860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: implications for autoimmunity.
    Smeltz RB; Wolf NA; Swanborg RH
    J Immunol; 1999 Aug; 163(3):1390-7. PubMed ID: 10415039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro expanded human invariant natural killer T-cells promote functional activity of natural killer cells.
    Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
    Clin Immunol; 2008 Oct; 129(1):145-54. PubMed ID: 18707922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructure of interactions between activated murine natural killer cells and melanoma cells in an extracellular matrix (Matrigel) environment.
    Johansson BR; Nannmark U
    Nat Immun; 1996-1997; 15(2-3):98-106. PubMed ID: 9162268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DC therapy induces long-term NK reactivity to tumors via host DC.
    Shimizu K; Fujii S
    Eur J Immunol; 2009 Feb; 39(2):457-68. PubMed ID: 19180466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.